NCCN May Already Be Updating MPN Guidelines
After publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).
Read More
Antibiotics May Compromise Immunotherapy Efficacy in Kidney Cancer
Patients with metastatic kidney cancer may see a decreased efficacy of their immunotherapy regimen if they recently took antibiotics.
The Need for Targeted Clinical Trials in ALL
There is a need for more targeted clinical trials for patients with ALL, since many of them have Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia.
Keytruda Benefits Rare Melanoma Subtype in Three Trials
Three recent trials showed that Keytruda had a durable response for patients with a rare subtype of melanoma.
Combo Shows No Additional Benefit in Glioblastoma
The combination of onartuzumab and Avastin (bevacizumab) showed no additional benefit for patients with glioblastoma, according to a recent study.
Menopause Symptoms Affect Treatment Adherence in Breast Cancer Survivors
Women who are experiencing symptoms of menopause often mistake those events as treatment side effects, leading to a decrease in adherence.
Progression-Free Survival Doubled With New Breast Cancer Combination
A subset of patients with breast cancer saw an increase in progression-free survival with the addition of Afinitor to Faslodex.
Expert Discusses Lynch-Like Syndrome in Rectal Cancer
Patients with DNA mismatch repair deficiency rectal cancer may not necessarily have Lynch syndrome. Expert Yi-Qian Nancy You weighs in on the topic.
